# Chemotherapy-Induced Changes to Cognition and DNA in Breast Cancer Survivors

> **NCT00496613** · — · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 200 (estimated)

## Conditions studied

- Breast Cancer
- Long-Term Survivors

## Interventions

- **BEHAVIORAL:** Mini-Mental State Exam and Blood draw
- **BEHAVIORAL:** Mini-Mental State Exam and Blood Draw
- **BEHAVIORAL:** Mini-Mental State Exam and Blood Draw

## Key facts

- **NCT ID:** NCT00496613
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2022-04-18
- **Final completion:** 2022-04-18
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00496613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00496613, "Chemotherapy-Induced Changes to Cognition and DNA in Breast Cancer Survivors". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00496613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*